Valuation: CaliPharms, Inc.

Market Cap 401K 348K 327K 298K 559K 38.3M 568K 3.84M 1.5M 19.2M 1.51M 1.47M 64M P/E 2012 *
-
P/E 2013 -0.51x
Enterprise Value 1.07M 926K 869K 792K 1.49M 102M 1.51M 10.21M 3.99M 51.08M 4.01M 3.92M 170M EV / Sales 2012 *
-
EV / Sales 2013 -
Free-Float
100%
Yield 2012 *
-
Yield 2013 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 13.88K
-0.18%-0.86%-9.81%-7.24% 13.37B
-0.55%-2.89%+3.42%+2.05% 5.01B
-0.16%-0.96%-31.83%-56.19% 5.06B
+1.91%+4.01%+6.21%-29.83% 4.16B
+0.19%-1.37%-13.03%-5.79% 3.66B
-0.75%-4.65%-6.68%-0.32% 3.44B
+0.78%-1.84%-5.34%+15.75% 3.39B
+0.82%+2.17%-12.38%-15.03% 2.48B
-3.91%-12.46%-15.14%+24.49% 1.71B
Average -0.18%-2.19%-9.40%-8.01% 4.7B
Weighted average by Cap. -0.05%-1.35%-9.33%-10.86%

Financials

2012 2013
Net sales - -
Net income -917K -795K -746K -680K -1.28M -87.5M -1.3M -8.77M -3.42M -43.86M -3.44M -3.37M -146M -216K -188K -176K -160K -301K -20.66M -307K -2.07M -809K -10.35M -813K -795K -34.52M
Net Debt 617K 535K 502K 457K 859K 58.85M 873K 5.9M 2.3M 29.5M 2.31M 2.26M 98.34M 667K 578K 543K 494K 928K 63.62M 944K 6.37M 2.49M 31.89M 2.5M 2.45M 106M
Logo CaliPharms, Inc.
CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also expanding into other sectors that support the legalized marijuana industry.
Employees
-